七彩化學(300758.SZ):擬與美聯新材設美彩新材、以投資25億元建年產18萬噸電池級普魯士藍(白)項目
格隆匯11月16日丨七彩化學(300758.SZ)公佈,公司於2022年11月16日召開第六屆董事會第十八次會議和第六屆監事會第十六次會議,審議通過了《關於對外投資暨關聯交易的議案》,同意公司與美聯新材共同出資設立遼寧美彩新材料有限公司(“標的公司”或“美彩新材”,最終以登記機關核准的名稱為準),並以該標的公司為實施主體投資25億元建設年產18萬噸電池級普魯士藍(白)項目。
標的公司註冊資本為5億元,其中,公司擬以貨幣及/或實物出資人民幣2.45億元,認繳標的公司的註冊資本2.45億元,佔標的公司註冊資本的49%;美聯新材擬以貨幣出資人民幣2.55億元,認繳標的公司的註冊資本2.55億元,佔標的公司註冊資本的51%。前述雙方的貨幣資金將使用自有或自籌資金。此次交易完成後,標的公司成為公司參股公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.